Chemoinformaics analysis of 3-Vinylpyridine
Molecular Weight | 105.14 | nRot | 1 |
Heavy Atom Molecular Weight | 98.084 | nRig | 7 |
Exact Molecular Weight | 105.058 | nRing | 1 |
Solubility: LogS | 0.103 | nHRing | 1 |
Solubility: LogP | 1.55 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 15 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 7 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
nHA | 1 | APOL | 17.4576 |
nHD | 0 | BPOL | 8.16245 |
QED | 0.53 |
Synth | 2.168 |
Natural Product Likeliness | -0.613 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.002 |
HIA | 0.005 |
CACO-2 | -4.217 |
MDCK | 0.0000379 |
BBB | 0.685 |
PPB | 0.535956 |
VDSS | 1.325 |
FU | 0.521419 |
CYP1A2-inh | 0.875 |
CYP1A2-sub | 0.504 |
CYP2c19-inh | 0.132 |
CYP2c19-sub | 0.787 |
CYP2c9-inh | 0.037 |
CYP2c9-sub | 0.37 |
CYP2d6-inh | 0.016 |
CYP2d6-sub | 0.782 |
CYP3a4-inh | 0.073 |
CYP3a4-sub | 0.286 |
CL | 12.879 |
T12 | 0.809 |
hERG | 0.033 |
Ames | 0.015 |
ROA | 0.765 |
SkinSen | 0.926 |
Carcinogencity | 0.375 |
EI | 0.991 |
Respiratory | 0.788 |
NR-Aromatase | 0.066 |
Antiviral | No |
Prediction | 0.882779 |